4.5 Article

Tumor-Resident Stromal Cells Promote Breast Cancer Invasion through Regulation of the Basal Phenotype

期刊

MOLECULAR CANCER RESEARCH
卷 18, 期 11, 页码 1615-1622

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-20-0334

关键词

-

资金

  1. Cancer Research UK
  2. Breast Cancer Research Foundation/Pink Agenda [BCRF-19-048]
  3. Commonwealth Foundation
  4. NIH/NCI [U01CA217846, U54CA2101732, 3P30CA006973]

向作者/读者索取更多资源

Collective invasion can be led by breast cancer cells expressing basal epithelial markers, typified by keratin-14 (KRT14). We analyzed gene expression data from The Cancer Genome Atlas and demonstrated a significant correlation between a KRT14thorn invasion signature and a stromal-mediated extracellular matrix (ECM) organization module. We then developed a novel coculture model of tumor organoids with autologous stromal cells. Coculture significantly increased KRT14 expression and invasion of organoids from both luminal and basal murine breast cancer models. However, stromal cell conditioned medium induced invasion but not KRT14 expression. Cancer cells released TGFb and that signaling pathway was required for stromal cell-induced invasion and KRT14 expression. Mechanistically, TGFb induced NOX4 expression in stromal cells and NOX4 inhibition reduced invasion and KRT14 expression. In summary, we developed a novel coculture model and revealed dynamic molecular interactions between stromal cells and cancer cells that regulate both basal gene expression and invasive behavior.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study

John N. Primrose, Sian A. Pugh, Gareth Thomas, Matthew Ellis, Karwan Moutasim, David Mant

Summary: This study aimed to use intratumoural immune signature to identify a subgroup of colorectal cancer patients with a very low relapse rate, thus reducing unnecessary follow-ups. However, due to hardware and software issues, as well as the loss of critical scientific staff, reliable data could not be obtained within the study timeframe, resulting in failure to achieve the original project goal.

HEALTH TECHNOLOGY ASSESSMENT (2021)

Review Oncology

Organoids in cancer research: a review for pathologist-scientists

Laura D. Wood, Andrew J. Ewald

Summary: The use of three-dimensional culture models, especially organoids, has greatly expanded in cancer research, providing valuable tools for studying cellular strategies and molecular mechanisms driving cancer initiation and progression. Organoids can be used for short-term acute cultures or long-term studies, and offer advantages in addressing specific research questions in cancer biology.

JOURNAL OF PATHOLOGY (2021)

Article Multidisciplinary Sciences

Epigenetically regulated digital signaling defines epithelial innate immunity at the tissue level

Helen R. Clark, Connor McKenney, Nathan M. Livingston, Ariel Gershman, Seema Sajjan, Isaac S. Chan, Andrew J. Ewald, Winston Timp, Bin Wu, Abhyudai Singh, Sergi Regot

Summary: Epithelial tissues respond to microbial patterns in a digital manner, activating a subset of cells through regulation of a bimodal epigenetic switch. Epigenetic licensing in individual cells allows for long-term, quantitative fine-tuning of population-level responses. Fine tuning the immune response according to the threat level is crucial for distinguishing between pathogens and commensal bacteria.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

On the role of p53 in the cellular response to aneuploidy

Akshay Narkar, Blake A. Johnson, Pandurang Bharne, Jin Zhu, Veena Padmanaban, Debojyoti Biswas, Andrew Fraser, Pablo A. Iglesias, Andrew J. Ewald, Rong Li

Summary: Studies suggest that p53 may not serve as a universal surveillance factor restricting the proliferation of aneuploid cells, but instead play a role in ensuring faithful chromosome transmission likely by preventing polyploidization and influencing spindle mechanics, both directly or indirectly.

CELL REPORTS (2021)

Article Engineering, Biomedical

Engineering a 3D collective cancer invasion model with control over collagen fiber alignment

Chia-Yi Su, Alice Burchett, Matthew Dunworth, Jong Seob Choi, Andrew J. Ewald, Eun Hyun Ahn, Deok-Ho Kim

Summary: A new 3D tumor model has been developed to recapitulate the response of tumors to different ECM structures and simulate tumor invasion through guided fiber alignment. This model provides a new tool for studying collective tumor invasion and holds potential for discovering therapeutic agents targeted against cancer invasion.

BIOMATERIALS (2021)

Article Cell Biology

Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis

Stephanie Torrino, Eloise M. Grasset, Stephane Audebert, Ilyes Belhadj, Caroline Lacoux, Meagan Haynes, Sabrina Pisano, Sophie Abelanet, Frederic Brau, Stephen Y. Chan, Bernard Mari, William M. Oldham, Andrew J. Ewald, Thomas Bertero

Summary: In this study, it was found that breast cancer cells respond to mechanical signals by rewiring glutamine metabolism to promote microtubule glutamylation and enhance microtubule stability, thereby promoting cell invasion. Inhibition of glutamine metabolism affects microtubule stability, while reducing microtubule glutamylation weakens cancer aggressiveness.

CELL METABOLISM (2021)

Article Immunology

Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy

Simon Eschweiler, James Clarke, Ciro Ramirez-Suastegui, Bharat Panwar, Ariel Madrigal, Serena J. Chee, Ioannis Karydis, Edwin Woo, Aiman Alzetani, Somaia Elsheikh, C. J. Hanley, G. J. Thomas, Peter S. Friedmann, Tilman Sanchez-Elsner, Ferhat Ay, Christian H. Ottensmeier, Pandurangan Vijayanand

Summary: Studies have shown the importance of T-FR cells within tumor tissues in enhancing the efficacy of anti-PD-1 therapy. Depleting or blocking T-FR cells can improve the effectiveness of anti-PD-1 treatment and contribute to better survival outcomes in melanoma patients.

NATURE IMMUNOLOGY (2021)

Article Oncology

DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer

Hetakshi Kurani, Seyedeh Fatemeh Razavipour, Kuzhuvelil B. Harikumar, Matthew Dunworth, Andrew J. Ewald, Apsra Nasir, Gray Pearson, Derek Van Booven, Zhiqun Zhou, Diana Azzam, Claes Wahlestedt, Joyce Slingerland

Summary: This study identified DOT1L as a key regulator of cancer stem cells (CSCs) in triple-negative breast cancer (TNBC). Inhibition of DOT1L suppressed the growth and metastasis of TNBC CSCs, suggesting that DOT1L inhibitors may be a potential therapeutic option for targeting stem cell-enriched TNBC.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research

Hillary Stires, Igor Bado, Thelma Brown, Martha Carlson, Isaac S. Chan, Gloria V. Echeverria, Andrew J. Ewald, Bora Lim, Carla Lloyd, Julia Maues, Steffi Oesterreich, Robert N. Riter, Kelly Shanahan, Alana L. Welm, Josh Newby

Summary: Incorporating patient advocates into basic cancer research can enhance research intentionality, effective communication, and direct connections between researchers and those they aim to help. However, many cancer research scientists do not collaborate with patient advocates. Through hosting workshops and discussing findings at an international conference, we identified barriers and provided actionable steps to support researchers in working with patient advocates to improve cancer research and achieve our collective goal.

NPJ BREAST CANCER (2022)

Article Oncology

ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance

Massimiliano Mellone, Klaudia Piotrowska, Giulia Venturi, Lija James, Aleksandra Bzura, Maria A. Lopez, Sonya James, Chuan Wang, Matthew J. Ellis, Christopher J. Hanley, Josephine F. Buckingham, Kerry L. Cox, Gareth Hughes, Viia Valge-Archer, Emma King, Stephen A. Beers, Vincent Jaquet, George D. D. Jones, Natalia Savelyeva, Emre Sayan, Jason L. Parsons, Stephen Durant, Gareth J. Thomas

Summary: Myofibroblastic cancer-associated fibroblast (myoCAF)-rich tumors have low T cell infiltration and poor response to immune-checkpoint blockade. This study identifies ATM as a central regulator of myoCAF differentiation, providing a potential therapeutic target for overcoming immunotherapy resistance in myoCAF-rich tumors.

CANCER RESEARCH (2022)

Article Cell Biology

Collective cell migration is spatiotemporally regulated during mammary epithelial bifurcation

Neil M. Neumann, Daniel M. Kim, Robert J. Huebner, Andrew J. Ewald

Summary: In this study, the process of bifurcation of mammary epithelium was investigated. The researchers observed changes in cell migration speed and the role of TGF-0 signaling in this process, revealing the mechanism behind mammary epithelial bifurcation.

JOURNAL OF CELL SCIENCE (2023)

Article Biochemistry & Molecular Biology

Triple negative breast tumors contain heterogeneous cancer cells expressing distinct KRAS-dependent collective and disseminative invasion programs

Elodie Henriet, Hildur Knutsdottir, Eloise M. M. Grasset, Matthew Dunworth, Meagan Haynes, Joel S. S. Bader, Andrew J. J. Ewald

Summary: Inter-patient and intra-tumoral heterogeneity makes it difficult to identify predictive biomarkers and effective treatments for basal triple negative breast cancer (b-TNBC). In this study, we cultured organoids from a b-TNBC mouse model and characterized their invasive behavior. By isolating individual organoids from collagen gels based on invasive morphology and performing RNA sequencing, we identified KRAS and ERK as essential regulators of collective and single cell dissemination. Inhibition of EGFR, MAPK/ERK, or PI3K/AKT signaling was found to reduce invasion.

ONCOGENE (2023)

Article Multidisciplinary Sciences

Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer

Christopher J. Hanley, Sara Waise, Matthew J. Ellis, Maria A. Lopez, Wai Y. Pun, Julian Taylor, Rachel Parker, Lucy M. Kimbley, Serena J. Chee, Emily C. Shaw, Jonathan West, Aiman Alzetani, Edwin Woo, Christian H. Ottensmeier, Matthew J. J. Rose-Zerilli, Gareth J. Thomas

Summary: Through single cell RNA-sequencing, multiplexed immunohistochemistry, and digital cytometry, three major fibroblast subpopulations in non-small cell lung cancer are identified and characterised. These subpopulations include adventitial, alveolar, and myofibroblasts. Myofibroblasts are associated with poor overall survival rates in lung adenocarcinomas, while their presence in squamous carcinomas does not have a prognostic value. These findings have important implications for the development of fibroblast-targeting strategies in cancer therapy.

NATURE COMMUNICATIONS (2023)

Review Medicine, Research & Experimental

The changing role of natural killer cells in cancer metastasis

Isaac S. Chan, Andrew J. Ewald

Summary: NK cells play a critical role in the body's defense against tumors and metastasis. Recent research has examined the interaction between metastatic cancer cells and NK cells. The unique biology of cancer cells at each stage of metastasis alters the fundamental biology of NK cells, including the ability of cancer cells to evade immune surveillance and manipulate NK cells to promote metastasis. This knowledge has potential translational applications in medicine.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Dentistry, Oral Surgery & Medicine

Cancer-Associated Fibroblasts in Oral Cancer: A Current Perspective on Function and Potential for Therapeutic Targeting

Kamila J. Bienkowska, Christopher J. Hanley, Gareth J. Thomas

Summary: The role of cancer-associated fibroblasts (CAF) in the microenvironment of oral cancer (OSCC) is crucial for promoting cancer progression and resistance to therapy. CAF with an activated myofibroblastic phenotype support OSCC progression and confer resistance to immuno- and targeted therapies, leading to poor prognosis in CAF-rich OSCC. Additionally, CAF shield tumors from immune attack through multiple mechanisms, particularly in promoting resistance to anti-PD-1/PD-L1 checkpoint inhibitors.

FRONTIERS IN ORAL HEALTH (2021)

暂无数据